CXCR2 and hepatocellular carcinoma: Inhibit the migration of hepatocellular carcinoma cells by downregulating migration-related chemokine receptors, such as CXCR1, CXCR2, and CXCR4; induce apoptosis in these cells via the caspase-3 pathway